BioMarin Pharmaceutical Inc. buy UBS Group AG
Start price
30.10.24
/
50%
€62.34
Target price
30.10.25
€97.65
Performance (%)
-19.87%
Price
09:31
€49.95
Summary
This prediction is currently active. The price of BioMarin Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.87%. This prediction currently runs until 30.10.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| BioMarin Pharmaceutical Inc. | -2.391% | -2.391% |
| iShares Core DAX® | 0.998% | 0.948% |
| iShares Nasdaq 100 | 1.965% | 4.491% |
| iShares Nikkei 225® | 4.258% | 8.018% |
| iShares S&P 500 | 2.037% | 3.420% |
Comments by UBS_Group_AG for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) had its price target raised by analysts at UBS Group AG from $104.00 to $106.00. They now have a "buy" rating on the stock.
Ratings data for BMRN provided by MarketBeat
Stopped prediction by UBS_Group_AG for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€51.06
05.08.25
05.08.25
€98.62
05.08.26
05.08.26
-2.17%
09:31
09:31
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€65.70
20.02.25
20.02.25
€108.05
20.02.26
20.02.26
-23.97%
09:31
09:31